Dr. Melissa Lucy Larusso, DO Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6 Greenwich Office Park, Greenwich, CT 06831 Phone: 203-869-1145 Fax: 203-618-1721 |
Lana Bernstein, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 49 Lake Ave, Suite 2, Greenwich, CT 06830 Phone: 203-869-5715 |
Anastasia Slobodnick, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 75 Holly Hill Ln Fl 2, Greenwich, CT 06830 Phone: 203-869-6960 Fax: 203-869-5103 |
News Archive
The U.S. Food and Drug Administration today announced that it has cleared a test to help manage potential organ rejection in kidney transplant patients. The test, called QMS Everolimus Immunoassay, monitors the blood level of everolimus, a drug that helps prevent rejection in kidney transplants.
Approximately 6 million Americans have brain aneurysms, a condition that occurs when a weak or thin spot develops on a blood vessel in the brain causing it to balloon. Often, these do not cause symptoms and go undetected, but every year an estimated 30,000 Americans experience a ruptured aneurysm that bleeds into the brain causing a life threatening injury.
On the same morning a congressional staffer told investors in a private call that odds were improving for a government decision that would help medical insurers, trading spiked in a major health-care company.
"We as Democrats respect the results of yesterday's special election in one state, Massachusetts, and will shortly welcome Senator-elect Scott Brown to Washington. In the same spirit I call upon our Republican colleagues to respect the results of the 50-state election that led to the inauguration, just one year ago today, of President Barack Obama. That 50-state election of 2008 produced overwhelming majorities in both houses of Congress for the Obama program of progress, dignity and equity, especially in his advocacy for comprehensive healthcare reform.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 5mg/ 5ml of Oxycodone HCl liquid which is used in treatment of moderate to severe acute and chronic pain. Wockhardt is launching the product soon and will be amongst the few generic versions of this product in the market.
› Verified 1 days ago